Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Inventory Average (2021 - 2025)

Maravai Lifesciences Holdings has reported Inventory Average over the past 5 years, most recently at $42.9 million for Q4 2025.

  • Quarterly results put Inventory Average at $42.9 million for Q4 2025, down 14.7% from a year ago — trailing twelve months through Dec 2025 was $42.9 million (down 14.7% YoY), and the annual figure for FY2025 was $45.3 million, down 10.74%.
  • Inventory Average for Q4 2025 was $42.9 million at Maravai Lifesciences Holdings, down from $46.0 million in the prior quarter.
  • Over the last five years, Inventory Average for MRVI hit a ceiling of $61.3 million in Q3 2022 and a floor of $40.2 million in Q1 2021.
  • Median Inventory Average over the past 5 years was $50.1 million (2023), compared with a mean of $50.1 million.
  • Biggest five-year swings in Inventory Average: rose 28.02% in 2022 and later dropped 21.21% in 2023.
  • Maravai Lifesciences Holdings' Inventory Average stood at $53.9 million in 2021, then fell by 2.07% to $52.8 million in 2022, then fell by 4.77% to $50.3 million in 2023, then grew by 0.08% to $50.3 million in 2024, then decreased by 14.7% to $42.9 million in 2025.
  • The last three reported values for Inventory Average were $42.9 million (Q4 2025), $46.0 million (Q3 2025), and $48.2 million (Q2 2025) per Business Quant data.